1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Renal Dialysis Equipment Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Renal Dialysis Equipment Market, North America 10
3.1 Renal Dialysis Equipment Market, North America, Revenue ($m), 2015-2025 10
3.2 Renal Dialysis Equipment Market, North America, Revenue ($m), 2015-2025 12
3.3 Renal Dialysis Equipment Market, North America, Volume (Units), 2015-2025 14
3.4 Renal Dialysis Equipment Market, North America, Volume (Units), 2015-2025 16
3.5 Renal Dialysis Equipment Market, North America, Company Share by Revenue ($m), 2019 18
4 Renal Dialysis Equipment Market, Canada 20
4.1 Renal Dialysis Equipment Market, Canada, Revenue ($m), 2015-2025 20
4.1.1 Dialysis Accessories Market, Canada, Revenue ($m), by Segment, 2015-2025 22
4.1.2 Dialysis Machines Market, Canada, Revenue ($m), by Segment, 2015-2025 25
4.1.3 Vascular Access Devices for Hemodialysis Market, Canada, Revenue ($m), by Segment, 2015-2025 27
4.2 Renal Dialysis Equipment Market, Canada, Volume (Units), 2015-2025 30
4.2.1 Dialysis Accessories Market, Canada, Volume (Units) by Segment, 2015-2025 32
4.2.2 Dialysis Machines Market, Canada, Volume (Units) by Segment, 2015-2025 35
4.2.3 Vascular Access Devices for Hemodialysis Market, Canada, Volume (Units) by Segment, 2015-2025 37
4.3 Renal Dialysis Equipment Market, Canada, Average Price ($), 2015-2025 40
4.4 Renal Dialysis Equipment Market, Canada, Distribution Share by Revenue ($m), 2019 42
4.5 Renal Dialysis Equipment Market, Canada, Company Share by Revenue ($m), 2019 43
5 Renal Dialysis Equipment Market, Mexico 45
5.1 Renal Dialysis Equipment Market, Mexico, Revenue ($m), 2015-2025 45
5.1.1 Dialysis Accessories Market, Mexico, Revenue ($m), by Segment, 2015-2025 47
5.1.2 Dialysis Machines Market, Mexico, Revenue ($m), by Segment, 2015-2025 50
5.1.3 Vascular Access Devices for Hemodialysis Market, Mexico, Revenue ($m), by Segment, 2015-2025 52
5.2 Renal Dialysis Equipment Market, Mexico, Volume (Units), 2015-2025 55
5.2.1 Dialysis Accessories Market, Mexico, Volume (Units) by Segment, 2015-2025 57
5.2.2 Dialysis Machines Market, Mexico, Volume (Units) by Segment, 2015-2025 60
5.2.3 Vascular Access Devices for Hemodialysis Market, Mexico, Volume (Units) by Segment, 2015-2025 62
5.3 Renal Dialysis Equipment Market, Mexico, Average Price ($), 2015-2025 65
5.4 Renal Dialysis Equipment Market, Mexico, Distribution Share by Revenue ($m), 2019 67
5.5 Renal Dialysis Equipment Market, Mexico, Company Share by Revenue ($m), 2019 68
6 Renal Dialysis Equipment Market, United States 70
6.1 Renal Dialysis Equipment Market, United States, Revenue ($m), 2015-2025 70
6.1.1 Dialysis Accessories Market, United States, Revenue ($m), by Segment, 2015-2025 72
6.1.2 Dialysis Machines Market, United States, Revenue ($m), by Segment, 2015-2025 75
6.1.3 Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), by Segment, 2015-2025 77
6.2 Renal Dialysis Equipment Market, United States, Volume (Units), 2015-2025 80
6.2.1 Dialysis Accessories Market, United States, Volume (Units) by Segment, 2015-2025 82
6.2.2 Dialysis Machines Market, United States, Volume (Units) by Segment, 2015-2025 85
6.2.3 Vascular Access Devices for Hemodialysis Market, United States, Volume (Units) by Segment, 2015-2025 87
6.3 Renal Dialysis Equipment Market, United States, Average Price ($), 2015-2025 90
6.4 Renal Dialysis Equipment Market, United States, Distribution Share by Revenue ($m), 2019 92
6.5 Renal Dialysis Equipment Market, United States, Company Share by Revenue ($m), 2019 93
7 Overview of Key Companies in North America, Renal Dialysis Equipment Market 95
7.1 Fresenius Medical Care AG & Co KGaA 95
7.1.1 Company Overview 95
7.2 Baxter International Inc 95
7.2.1 Company Overview 95
7.3 Nipro Corp 95
7.3.1 Company Overview 95
7.4 B. Braun Melsungen AG 96
7.4.1 Company Overview 96
7.5 Asahi Kasei Corp 96
7.5.1 Company Overview 96
7.6 CR Bard Inc 96
7.6.1 Company Overview 96
7.7 Toray Medical Co Ltd 97
7.7.1 Company Overview 97
7.8 Medtronic plc 97
7.8.1 Company Overview 97
8 Vascular Access Devices for Hemodialysis Market Pipeline Products 98
9 Recent Developments 99
9.1 Corporate Communications 99
9.1.1 Mar 25, 2020: Specialty Renal Products announces appointment of Tony Robinson as Vice President of Operations 99
9.1.2 Mar 09, 2020: Rockwell Medical Offered $15 Million by Medical Resource Acquisition Group 99
9.1.3 Feb 03, 2020: Rockwell Medical announces proposed public offering of common stock 100
9.1.4 Nov 01, 2019: Rockwell Medical Appoints John P. McLaughlin Chairman of the Board of Directors 100
9.1.5 Sep 05, 2019: Rockwell Medical appoints Industry Veteran John P. McLaughlin to Board of Directors 101
9.1.6 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 102
9.1.7 Jun 27, 2019: Baxter highlights progress toward its 2020 corporate responsibility goals and efforts to make a meaningful difference around the world 102
9.1.8 May 01, 2019: Nephros names Tom Gwydir to its Board of Directors 103
9.1.9 Apr 30, 2019: Renal Research Institute Receives KidneyX Award for Displacer-Enhanced Dialysis 103
9.2 Financial Announcements 104
9.2.1 Mar 05, 2020: OPKO Health's BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test 104
9.2.2 Feb 27, 2020: Nephros reports 2019 fourth quarter and full year financial results 105
9.2.3 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 106
9.2.4 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 108
9.2.5 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 110
9.2.6 Jan 13, 2020: Chi-Med initiates a phase II Trial of surufatinib in combination with Tuoyi in patients with advanced solid tumors 111
9.2.7 Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance 113
9.2.8 Jan 06, 2020: Nephros announces preliminary financial results for fourth quarter and fiscal year 2019 114
9.2.9 Nov 11, 2019: Rockwell Medical reports third quarter 2019 financial results 115
9.2.10 Nov 06, 2019: Nephros reports third quarter financial results 117
9.2.11 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 117
9.2.12 Oct 29, 2019: Cynosure extends body contouring portfolio with launch of StimSure in Europe 120
9.2.13 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 122
9.2.14 Oct 24, 2019: Rockwell Medical provides business update 124
9.2.15 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 126
9.2.16 Oct 07, 2019: Nephros announces preliminary financial results for third quarter 2019 127
9.2.17 Sep 17, 2019: Novita signs key UK partner supply agreement 128
9.2.18 Aug 08, 2019: Rockwell Medical reports second quarter 2019 financial results 129
9.2.19 Aug 07, 2019: Nephros reports second quarter financial results 132
9.2.20 Aug 02, 2019: Researchers from the IDIBELL and the University of Barcelona describe a new treatment that could cope with 2 bone diseases 133
9.2.21 Jul 25, 2019: Baxter reports second-quarter 2019 results 134
9.2.22 Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019 135
9.2.23 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 138
9.2.24 Jul 09, 2019: Nephros announces preliminary financial results for second quarter 2019 and reverse stock split 140
9.2.25 Jun 25, 2019: Pepscan produces clinical peptides for innovative personalized cancer vaccine trial 140
9.2.26 May 09, 2019: Rockwell Medical reports first quarter 2019 financial results 142
9.2.27 May 08, 2019: Nephros reports first quarter financial results 143
9.2.28 May 06, 2019: FDA grants Breakthrough Device designation to Natera's Signatera test 144
9.2.29 Apr 25, 2019: Baxter reports first-quarter 2019 results 145
9.2.30 Apr 24, 2019: Boston Scientific announces results for first quarter 2019 146
9.2.31 Apr 23, 2019: Merit Medical announces earnings for quarter ended March 31, 2019 147
9.2.32 Apr 08, 2019: Nephros announces preliminary financial results for first quarter 2019 148
9.3 Government and Public Interest 148
9.3.1 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 148
9.4 Legal And Regulatory 149
9.4.1 Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter 149
9.4.2 Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International 150
9.5 Other Significant Developments 150
9.5.1 Dec 09, 2019: Two RCSI research projects funded by the disruptive technology innovation fund 150
9.5.2 Oct 31, 2019: Trump Administration strengthens medicare by fostering innovation and modernizing payment methodologies to provide kidney patients with better value and results 151
9.5.3 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica 152
9.5.4 Jul 10, 2019: Fresenius Medical invests in remote monitoring firm BioIntelliSense 153
9.6 Strategy And Business Planning 153
9.6.1 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 153
9.6.2 Jul 10, 2019: Baxter supports advancing american kidney health initiative and plans Significant U.S. investment to help drive implementation 154
9.6.3 Jun 25, 2019: Fresenius Medical Care North America joins FirstNet – America's Public Safety Communications Platform 155
9.6.4 Jun 24, 2019: Boston Scientific Galway expands in to new facility 156
9.6.5 Apr 09, 2019: Merit Medical announces opening of new office in Johannesburg, South Africa 156
10 Appendix 158
10.1 Research Methodology 159
10.1.1 Coverage 159
10.1.2 Secondary Research 159
10.1.3 Primary Research 160
10.1.4 Market Modeling and Forecasting 160
10.1.5 Company Share Analysis 162
10.1.6 Distribution Share Analysis 162
10.1.7 Benchmarking 163
10.2 GlobalData Consulting 163
10.3 Contact Us 164
10.4 Disclaimer 164